chevron_leftBack
As of 20 June 2026, Zenith Drugs Ltd. has a market cap of $7.2M USD, ranking #42934 globally and #3560 in India.
It ranks #3798 in the Healthcare sector, and #1229 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$7.2MUSD
679.95M INR
Enterprise Value
$12.64MUSD
1.19B INR
Revenue (TTM)
$15.24MUSD
1.44B INR
EBITDA (TTM)
$1.44MUSD
136.08M INR
Net Income (TTM)
$400.21KUSD
37.77M INR
EBITDA Margin
9.5%
Profit Margin
2.6%
PE Ratio
18.0
PS Ratio
0.5
PB Ratio
0.9
EV/EBITDA
8.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sandeep Bhardwaj
open_in_new
Employees
182
Founded
1956
Website
zenithdrugs.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.8% | -13% | 4.1% | -15% | -39% | -49% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ZENITHDRUG
Zenith Drugs Ltd
ISIN: INE0QWN01013
Shares Out.:
Shares Outstanding:
17.149M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
39.95 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zenith Drugs Ltd.
Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated in 1956 and is based in Indore, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
628K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
255K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
210K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
163K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
137K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
135K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
11M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
8M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
5M%
|
97.4
|
|
SIX: RO
|
$318.3B
4M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
4M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
4M%
|
15.1
|
chevron_leftBack